These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7744129

  • 1. Nabumetone, an effective anti-inflammatory agent, lacks gastrointestinal irritancy in the rat when dosed orally for one month: comparison with tiaprofenic acid and etodolac.
    Melarange R, Gentry C, Blower PR, Toseland CD, Spangler R.
    Eur J Rheumatol Inflamm; 1994; 14(2):15-22. PubMed ID: 7744129
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac.
    Melarange R, Gentry C, Durie M, O'Connell C, Blower PR.
    Dig Dis Sci; 1994 Mar; 39(3):601-8. PubMed ID: 8131699
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration.
    Melarange R, Blower P, Spangler R.
    Eur J Rheumatol Inflamm; 1994 Mar; 14(2):23-7. PubMed ID: 7744130
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac.
    Melarange R, Gentry C, O'Connell C, Blower PR.
    Agents Actions Suppl; 1991 Mar; 32():33-7. PubMed ID: 2069095
    [Abstract] [Full Text] [Related]

  • 5. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
    Melarange R, Gentry C, O'Connell C, Blower PR, Neil C, Kelvin AS, Toseland CD.
    Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
    [Abstract] [Full Text] [Related]

  • 6. Economic and gastrointestinal safety comparisons of etodolac, nabumetone, and oxaprozin from insurance claims data from patients with arthritis.
    Simon LS, Zhao SZ, Arguelles LM, Lefkowith JB, Dedhiya SD, Fort JG, Johnson KE.
    Clin Ther; 1998 Dec; 20(6):1218-35; discussion 1192-3. PubMed ID: 9916614
    [Abstract] [Full Text] [Related]

  • 7. Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat.
    Melarange R, Gentry C, Toseland CD, Smith PH, Fuller J.
    Dig Dis Sci; 1995 Dec; 40(12):2694-703. PubMed ID: 8536533
    [Abstract] [Full Text] [Related]

  • 8. Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee.
    Schnitzer TJ, Ballard IM, Constantine G, McDonald P.
    Clin Ther; 1995 Dec; 17(4):602-12. PubMed ID: 8565024
    [Abstract] [Full Text] [Related]

  • 9. Gastrointestinal toxicity of newer NSAIDs.
    Lanza FL.
    Am J Gastroenterol; 1993 Sep; 88(9):1318-23. PubMed ID: 8362824
    [Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
    Melarange R, Gentry C, O'Connell C, Blower PR, Neil C, Kelvin AS, Toseland CD.
    Agents Actions; 1992 Sep; Spec No():C82-3. PubMed ID: 1442340
    [Abstract] [Full Text] [Related]

  • 11. Gastrointestinal damage demonstrated with nabumetone or etodolac in preclinical studies.
    Spangler RS.
    Am J Med; 1993 Aug 09; 95(2A):35S-39S. PubMed ID: 8357001
    [Abstract] [Full Text] [Related]

  • 12. Etodolac (Lodine) in the treatment of osteoarthritis: recent studies.
    Schnitzer TJ, Constantine G.
    J Rheumatol Suppl; 1997 Feb 09; 47():23-31. PubMed ID: 9035017
    [Abstract] [Full Text] [Related]

  • 13. Comparison of gastrointestinal blood loss in healthy male volunteers during repeated administration of standard and sustained action tiaprofenic acid and sustained release indomethacin.
    Warrington SJ, Dana-Haeri J, Horton MA, Thornton EJ.
    Drugs; 1988 Feb 09; 35 Suppl 1():90-4. PubMed ID: 3258815
    [Abstract] [Full Text] [Related]

  • 14. Safety profiles of leading nonsteroidal anti-inflammatory drugs.
    Rothstein R.
    Am J Med; 1998 Nov 02; 105(5A):39S-43S. PubMed ID: 9855175
    [Abstract] [Full Text] [Related]

  • 15. Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy following acute exposure to OTC non-steroidal anti-inflammatory agents and other gastric irritants.
    Carryl OR, Spangler RS.
    Scand J Rheumatol; 1995 Nov 02; 24(6):336-41. PubMed ID: 8610216
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 02; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 17. Low direct cytotoxicity of nabumetone on gastric mucosal cells.
    Arai Y, Tanaka K, Ushijima H, Tomisato W, Tsutsumi S, Aburaya M, Hoshino T, Yokomizo K, Suzuki K, Katsu T, Tsuchiya T, Mizushima T.
    Dig Dis Sci; 2005 Sep 02; 50(9):1641-6. PubMed ID: 16133963
    [Abstract] [Full Text] [Related]

  • 18. Upper gastrointestinal safety with nabumetone.
    Roth SH.
    J Rheumatol Suppl; 1992 Nov 02; 36():74-9. PubMed ID: 1474539
    [Abstract] [Full Text] [Related]

  • 19. The effect of terpenes on percutaneous absorption of tiaprofenic acid gel.
    Okyar A, Nuriyev M, Yildiz A, Pala-Kara Z, Ozturk N, Kaptan E.
    Arch Pharm Res; 2010 Nov 02; 33(11):1781-8. PubMed ID: 21116781
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
    Nishihara K, Kikuchi H, Kanno T, Tanabe S, Sarashina T, Uzuka Y.
    J Vet Med Sci; 2001 Oct 02; 63(10):1131-3. PubMed ID: 11714031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.